JNJ

239.13

+0.39%↑

UNH

272.01

-0.45%↓

TMO

538.23

-4.32%↓

ABT

109.59

+0.95%↑

ISRG

486.71

+1.01%↑

JNJ

239.13

+0.39%↑

UNH

272.01

-0.45%↓

TMO

538.23

-4.32%↓

ABT

109.59

+0.95%↑

ISRG

486.71

+1.01%↑

JNJ

239.13

+0.39%↑

UNH

272.01

-0.45%↓

TMO

538.23

-4.32%↓

ABT

109.59

+0.95%↑

ISRG

486.71

+1.01%↑

JNJ

239.13

+0.39%↑

UNH

272.01

-0.45%↓

TMO

538.23

-4.32%↓

ABT

109.59

+0.95%↑

ISRG

486.71

+1.01%↑

JNJ

239.13

+0.39%↑

UNH

272.01

-0.45%↓

TMO

538.23

-4.32%↓

ABT

109.59

+0.95%↑

ISRG

486.71

+1.01%↑

Search

Simulations Plus Inc

Abierto

SectorSanidad

14.08 -3.83

Resumen

Variación precio

24h

Actual

Mínimo

13.96

Máximo

14.74

Métricas clave

By Trading Economics

Ingresos

1.4M

676K

Ventas

961K

18M

P/B

Media del Sector

48.528

84.243

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

3.67

Empleados

212

EBITDA

-3M

2.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+28.21% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.28%

Próximas Ganancias

2 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-30M

338M

Apertura anterior

17.91

Cierre anterior

14.08

Noticias sobre sentimiento de mercado

By Acuity

28%

72%

59 / 352 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 feb 2026, 23:57 UTC

Ganancias

Naver Has Record Year Despite Weaker Final Quarter

5 feb 2026, 23:45 UTC

Acciones populares

Stocks to Watch: Amazon, Coty, Gen Digital, Roblox

5 feb 2026, 22:26 UTC

Ganancias

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9% -- Update

5 feb 2026, 22:00 UTC

Ganancias

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9%

5 feb 2026, 23:47 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

5 feb 2026, 23:47 UTC

Charlas de Mercado

Nikkei May Fall After U.S. Tech Stock Drops -- Market Talk

5 feb 2026, 23:43 UTC

Charlas de Mercado

Gold Falls on Spillover Impact From Cryptocurrencies' Selloff -- Market Talk

5 feb 2026, 23:37 UTC

Charlas de Mercado

Glencore Shares Look Cheap After Failed Takeover Talks -- Market Talk

5 feb 2026, 23:20 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 5th Update

5 feb 2026, 23:11 UTC

Charlas de Mercado

Amazon CEO Confident in Return on $200B Investment -- Market Talk

5 feb 2026, 23:09 UTC

Ganancias

Naver 2025 Net KRW1.820T Vs. Net KRW1.932T >035420.SE

5 feb 2026, 23:08 UTC

Ganancias

Naver 2025 Oper Pft KRW2.208T Vs. Pft KRW1.979T >035420.SE

5 feb 2026, 23:07 UTC

Ganancias

Naver 2025 Rev KRW12.035T Vs. KRW10.738T >035420.SE

5 feb 2026, 23:03 UTC

Charlas de Mercado
Ganancias

REA's Update Looks Negative Despite A$200M Buyback -- Market Talk

5 feb 2026, 23:03 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Bitcoin Booster's $12 Billion Loss Headlines Crypto's Worst Day Since 2022 Crash -- WSJ

5 feb 2026, 23:00 UTC

Ganancias

Naver 4Q Net Profit Missed FactSet-Compiled Consensus

5 feb 2026, 23:00 UTC

Ganancias

Naver 4Q Net KRW164.60B Vs. Net KRW514.00B >035420.SE

5 feb 2026, 22:59 UTC

Ganancias

Naver 4Q Oper Pft KRW610.60B Vs. Pft KRW542.00B >035420.SE

5 feb 2026, 22:59 UTC

Ganancias

Naver 4Q Rev KRW3.195T Vs. KRW2.886T >035420.SE

5 feb 2026, 22:52 UTC

Ganancias

Alphabet Stock Is Taking a Hit After Strong Earnings. Don't Panic. -- Barrons.com

5 feb 2026, 22:45 UTC

Ganancias

Amazon Stock Falls Sharply on Earnings. Spending Continues to Soar. -- Barrons.com

5 feb 2026, 22:37 UTC

Charlas de Mercado

Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk

5 feb 2026, 22:11 UTC

Ganancias

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9% -- Update

5 feb 2026, 22:03 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 4th Update

5 feb 2026, 22:01 UTC

Ganancias

Reddit Stock Jumps on Earnings. CFO Cites Modest AI Spending. -- Barrons.com

5 feb 2026, 21:59 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

What's Next For Rio Tinto, Glencore After Deal Talks Fail? -- Market Talk

5 feb 2026, 21:51 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Saylor's Strategy Posts $12 Billion Quarterly Loss on Bitcoin Selloff -- WSJ

5 feb 2026, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

5 feb 2026, 21:49 UTC

Ganancias

Why Google's Bad News Was Good News for Broadcom and Nvidia -- Barrons.com

5 feb 2026, 21:45 UTC

Ganancias

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9%

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

28.21% repunte

Estimación a 12 Meses

Media 19 USD  28.21%

Máximo 19 USD

Mínimo 19 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

59 / 352 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat